MR diffusion studies differentiate prostate cancer
Contrast-enhanced MR diffusion and perfusion were able to differentiate between central gland prostate cancer and benign prostate hyperplasia, according to a study published in Radiology.
Contrast-enhanced MR diffusion and perfusion were able to differentiate between central gland prostate cancer and benign prostate hyperplasia, according to a study published in Radiology.
The apparent diffusion coefficient differs significantly between central gland carcinoma, stromal hyperplasia, and glandular hyperplasia. Using ADC can help physicians distinguish between cancerous and benign tissue. In addition, combining the rate of contrast transfer between blood and tissue with the ADC can also aid the detection of central gland cancer.
In their retrospective study, the University of Chicago researchers included 49 patients who underwent endorectal MR imaging followed by radical prostatectomy, 26 of whom had central gland cancer.
The researchers found the ADC was 1.05 for central gland carcinoma, 1.27 for stromal hyperplasia foci, and 1.73 for glandular hyperplasia foci. Perfusion parameters were similar in central gland carcinomas and stromal hyperplasia foci. Adding the contrast agent transfer rate between blood and tissue to the ADC increased sensitivity from 38% to 57%. Adding the contrast agent transfer rate between blood and tissue to the ADC increased specificity to 90%.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 4th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 4th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
August 4th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
